Summary
DELAPHARMA is a financial institution; the bankruptcy model is trained on trading and manufacturing companies and does not apply here. The 2025 annual accounts show equity of €1.25M and a net result of €-93k. Equity is growing by ~13% per year across the filed fiscal years. Its solvency ranks better than 36% of 5547 sector peers (fiscal year 2025). The company has been active since 2004 and the Belgian State Gazette contains no insolvency or warning signals.
Checked score
Outside the general model
Model not applicable to financial institutions
The health score weighs liquidity, leverage and margins against norms for trading and manufacturing companies. A bank, insurer or financial holding has a fundamentally different balance-sheet structure, so those ratios, and hence the score, carry no meaning here. That is why we show no financial axes either.
Credit check for your own amount and term
Open the credit simulator : see how the verdict changes with amount, term and advance.
Signals
1 signal. The signal on the left, the evidence on the right.
○neutral
neutral · Latest accounts filed on time
The financial year that closed on 30-09-2025 was due by 30-04-2026 and was filed on 01-04-2026, 29 days ahead of the deadline.
NBB · 10 filingsDeviation from the deadline
2025
29 d early
2024
on the day
2023
1 d early
2022
3 d early
2021
4 d early
2020
45 d early
2019
31 d early
← before the deadline
after the deadline →
Checked, nothing found (2)
neutral · The next deadline is still running
The next financial year closes on 30-09-2026 and is due by 30-04-2027. Nothing is late today.
Companies Code · seven monthsPosition in the running window
25-09-2026 today30-09-2026 close30-04-2027 deadline
History
Financials · fiscal year 2025, abbreviated schema
Equity
€1.25M▼ 6.9%
2024 · €1.35M
Net result
€-93k
2024 · €341k
Total assets
€3.50M▲ 3.8%
2024 · €3.38M
Solvency
35.8%▼ 4.1pp
2024 · 39.9%
Trend over the years
Click a name to add, emphasise or remove a line.
Every figure with its change against the fiscal year before
favourable
unfavourable
Line20212022202320242025
Operating result€35k▼ 64.9%€29k▼ 17.1%€22k▼ 22.6%€-165k€-89k▲ 46.1%
Net result€377k▲ 465%€14k▼ 96.3%€13k▼ 7.4%€341k▲ 2,541%€-93k
Equity€978k▲ 62.1%€992k▲ 1.4%€1.00M▲ 1.3%€1.35M▲ 34.0%€1.25M▼ 6.9%
Total assets€1.64M▲ 114%€2.12M▲ 29.0%€2.68M▲ 26.4%€3.38M▲ 26.1%€3.50M▲ 3.8%
Debt€663k▲ 305%€1.12M▲ 69.7%€1.67M▲ 48.6%€2.03M▲ 21.4%€2.25M▲ 10.9%
Working capital€-35k▲ 29.7%€-354k▼ 913%€-1.05M▼ 196%€-1.57M▼ 49.7%€-1.80M▼ 14.4%
Solvency59.6%▼ 19.0pp46.9%▼ 12.7pp37.5%▼ 9.3pp39.9%▲ 2.3pp35.8%▼ 4.1pp
Turnover and EBIT margin not published: the abbreviated schema does not require them.
Result per fiscal year
Operating resultNet result
The operating result stays negative: a loss of €89k in 2025 against €165k in 2024; the loss shrinks.
Balance-sheet composition
2025 in colour, 2024 as the grey bar beneath
Assets €3.50M
Fixed assets
€3.41M ▲ 3.1%
Current assets
€97k ▲ 39.4%
Equity and liabilities €3.50M
Equity
€1.25M ▼ 6.9%
Debt
€2.25M ▲ 10.9%
Debt's share of the balance-sheet total rises from 60.1% to 64.2%. Equity is lower and debt is higher.
Key figures and ratios
ROE
-7.4%▼
2024 · 25.4%
ROA
-2.7%▼
2024 · 10.1%
Debt ≤ 1 year
€1.90M▲
2024 · €1.64M
Debt > 1 year
€355k▼
2024 · €388k
Green means a favourable move, even when the figure itself falls: as with debt or debt to equity.
Annual accounts
| Line | 2021 | 2022 | 2023 | 2024 | 2025 | Change |
|---|---|---|---|---|---|---|
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630 | €86k | €127k | €182k | €324k | €157k | ▼ 51.5% |
| Other operating charges640/8 | €1k | €1k | €2k | €2k | €4k | ▲ 177% |
| Gross operating margin9900 | €122k | €157k | €206k | €161k | €72k | ▼ 54.9% |
| Operating profit (loss)9901 | €35k | €29k | €22k | €-165k | €-89k | ▲ 46.1% |
| Financial income75/76B | €400k | €748 | €1k | €525k | - | - |
| Recurring financial income75 | €400k | €748 | €1k | €525k | - | - |
| Financial charges65/66B | €19k | €10k | €6k | €5k | €4k | ▼ 13.1% |
| Recurring financial charges65 | €19k | €10k | €6k | €5k | €4k | ▼ 13.1% |
| Profit (loss) for the period before taxes9903 | €415k | €19k | €17k | €355k | €-93k | ▼ 126% |
| Income taxes67/77 | €38k | €5k | €4k | €14k | - | - |
| Profit (loss) for the period9904 | €377k | €14k | €13k | €341k | €-93k | ▼ 127% |
| Profit (loss) for the period to be appropriated9905 | €377k | €14k | €13k | €341k | €-93k | ▼ 127% |
| Line | 2021 | 2022 | 2023 | 2024 | 2025 | Change |
|---|---|---|---|---|---|---|
| Assets | ||||||
| Total assets20/58 | €1.64M | €2.12M | €2.68M | €3.38M | €3.50M | ▲ 3.8% |
| Fixed assets21/28 | €1.08M | €1.82M | €2.47M | €3.31M | €3.41M | ▲ 3.1% |
| Tangible fixed assets22/27 | €362k | €1.10M | €1.76M | €2.59M | €2.69M | ▲ 3.9% |
| Land and buildings22 | €362k | €1.10M | €1.76M | €2.58M | €2.60M | ▲ 0.8% |
| Plant, machinery and equipment23 | - | - | - | €5k | - | - |
| Furniture and vehicles24 | - | - | - | - | €84k | - |
| Financial fixed assets28 | €718k | €718k | €718k | €718k | €718k | = |
| Current assets29/58 | €562k | €299k | €203k | €70k | €97k | ▲ 39.4% |
| Amounts receivable within one year40/41 | €7k | €14k | €30k | €38k | €20k | ▼ 46.9% |
| Trade receivables40 | €7k | - | €30k | €30k | €15k | ▼ 50.0% |
| Other amounts receivable41 | - | €14k | - | €8k | €5k | ▼ 34.6% |
| Cash at bank and in hand54/58 | €554k | €284k | €172k | €31k | €76k | ▲ 143% |
| Deferred charges and accrued income490/1 | - | - | - | €763 | €1k | ▲ 58.6% |
| Equity and liabilities | ||||||
| Total equity and liabilities10/49 | €1.64M | €2.12M | €2.68M | €3.38M | €3.50M | ▲ 3.8% |
| Equity10/15 | €978k | €992k | €1.00M | €1.35M | €1.25M | ▼ 6.9% |
| Contributions10/11 | €19k | €19k | €19k | €19k | €19k | = |
| Outside capital11 | €19k | €19k | €19k | - | - | - |
| Other1109/19 | €19k | €19k | €19k | - | - | - |
| Reserves13 | €957k | €971k | €984k | €1.33M | €1.23M | ▼ 7.0% |
| Non-distributable reserves130/1 | €19k | €19k | €19k | - | - | - |
| Reserves not available under the articles1311 | €19k | €19k | €19k | - | - | - |
| Distributable reserves133 | €938k | €952k | €965k | €1.33M | €1.23M | ▼ 7.0% |
| Profit (loss) carried forward14 | €3k | €3k | €3k | - | - | - |
| Amounts payable17/49 | €663k | €1.12M | €1.67M | €2.03M | €2.25M | ▲ 10.9% |
| Amounts payable after more than one year17 | €52k | €471k | €420k | €388k | €355k | ▼ 8.3% |
| Financial debts170/4 | €52k | €471k | €420k | €388k | €355k | ▼ 8.3% |
| Amounts payable within one year42/48 | €597k | €653k | €1.25M | €1.64M | €1.90M | ▲ 15.5% |
| Current portion of amounts payable after more than one year42 | €34k | €66k | €54k | €32k | €32k | ▲ 1.0% |
| Trade debts44 | €8k | €29k | €232k | €2k | €15k | ▲ 646% |
| Suppliers440/4 | €8k | €29k | €232k | €2k | €15k | ▲ 646% |
| Taxes, remuneration and social security45 | €18k | €17k | €26k | €99k | €8k | ▼ 91.9% |
| Taxes450/3 | €18k | €17k | €25k | €98k | €8k | ▼ 91.8% |
| Remuneration and social security454/9 | - | - | €1k | €1k | - | - |
| Other amounts payable47/48 | €537k | €542k | €941k | €1.51M | €1.84M | ▲ 22.0% |
| Accrued charges and deferred income492/3 | €14k | €179 | €73 | - | - | - |
| Line | 2021 | 2022 | 2023 | 2024 | 2025 | Change |
|---|---|---|---|---|---|---|
| Profit (loss) for the period9904 | €377k | €14k | €13k | €341k | €-93k | ▼ 127% |
| + Depreciation and write-downs630 | €86k | €127k | €182k | €324k | €157k | ▼ 51.5% |
| Operating cash flow (approximation) | €464k | €141k | €195k | €666k | €64k | ▼ 90.4% |
| Investment in fixed assets (approximation) | - | €-866k | €-838k | €-1.16M | €-258k | ▲ 77.6% |
| Change in cash | - | €-270k | €-112k | €-141k | €45k | ▲ 132% |
Simplified and derived: a Belgian filing has no cash-flow statement, so these rows come from the income statement and the balance-sheet moves.
More with these figures Sector benchmark What changed Value indication
Timeline · acts, filings and financial milestones
Next filing, fiscal year 2026, expected by
2026
01-04
NBB filing
Annual accounts filed
fiscal year 2025 · abbreviated schema
2025
30-09
Financial
Weakest financial yearnet €-93k
Net result drops to €-93k, the lowest in the series.
30-04
NBB filing
Annual accounts filed
fiscal year 2024 · abbreviated schema
2024
29-04
NBB filing
Annual accounts filed
fiscal year 2023 · abbreviated schema
2023
30-09
Financial
Equity above €1MEq €1.00M ▲1.3%
6 profitable years in a row build equity to €1.00M.
27-04
NBB filing
Annual accounts filed
fiscal year 2022 · abbreviated schema
2022
26-04
NBB filing
Annual accounts filed
fiscal year 2021 · abbreviated schema
2021
30-09
Financial
Highest result since 2018net €377k ▲465%
Net result €377k, the highest in the series.
16-03
NBB filing
Annual accounts filed
fiscal year 2020 · abbreviated schema
2020
30-03
NBB filing
Annual accounts filed
fiscal year 2019 · abbreviated schema
2019
30-09
Financial
Equity above €500kEq €539k ▲44.7%
2 profitable years in a row build equity to €539k.
11-03
NBB filing
Annual accounts filed
fiscal year 2018 · abbreviated schema
2018
12-03
NBB filing
Annual accounts filed
fiscal year 2017 · abbreviated schema
2017
16-03
NBB filing
Annual accounts filed
fiscal year 2016 · abbreviated schema
Financial milestoneNBB filingFinancial milestones sit on the fiscal year-end date, not the filing date.
0 of 2 acts read
About the unread acts
We know of 2 Belgian State Gazette acts for this company. None of them has been read yet: what they contain is neither established nor disproved here.
Have them read with priority
Sign in to place this company at the front of the reading queue.
Directors · office · real estate
Directors
2 acts for this company are in the Belgian State Gazette, of which we have read 0. We have therefore not extracted its directors from those acts yet.
Location & real-estate footprint
Registered office, Diksmuide · 1 establishment unit since 2004
Ground area
211 m²
Building footprint
211 m²
Volume, LiDAR
1,390 m³
Parcel 32003A0202/00D002, Flanders · tallest building 11.8 m, ±2 floors. Linked by address, not a title deed.
1 establishment unit
DELAPHARMA
since 20042.142.308.445
1 parcel
Flanders
1
(100%)
| Parcel (capakey) | Region | Area | Buildings | Height / fl. |
|---|---|---|---|---|
| 32003A0202/00D002 | Flanders | 211 m² | 1 · 211 m² | 11.8 m · 2 fl. |
Linked by address, not proof of ownership
Good to know
1 of 1 parcel with an exact address match; the rest are indicative.
Linked through address data, this is not proof of ownership.
1 of these parcels carry protected heritage: expect extra rules on renovation or sale.
Similar companies · same sector, comparable size
GAVRA IMMO
BE 0779.263.752
Geel · Eq €1,253,323
VEHTEC
BE 0458.123.575
Lier · Eq €1,253,325
Abo-Culture
BE 0864.564.166
Oudenburg · Eq €1,252,743
CHRISTIAAN POSTELMANS
BE 0807.943.187
Gent · Eq €1,252,741
COMAN
BE 0449.758.613
Hamont-Achel · Eq €1,252,723
Of 24,730 companies in sector 64210 we hold annual accounts for 19,766. 12,176 are within a factor 10 of this equity. The 5 above are the closest to it. See the whole sector
Identification & contact
Identification
Legal formPrivate limited company
Founded13-10-2004
Fiscal year end30-09
Activities, NACEBEL 2025
64210Activities of holding companies
Scores and ratios are computed by Checked and are not a credit decision.